Clinical Trials on Colorectal Cancer (CRC) in Japan
Total 1176 results
-
Kyowa Kirin Co., Ltd.Completed
-
Eli Lilly and CompanyCompleted
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedPancreatic CancerJapan
-
Taiho Pharmaceutical Co., Ltd.Yakult Honsha Co., LTDCompletedGastric CancerJapan, Korea, Republic of
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Kyoto UniversityTerminated
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
SanofiActive, not recruiting
-
Tohoku UniversityCompleted
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Translational Research Center for Medical Innovation...Kyoto Breast Cancer Research NetworkCompleted
-
Eisai Co., Ltd.Completed
-
AstraZenecaDaiichi SankyoRecruitingGastric Cancer | Colorectal Cancer | Ovarian Cancer | Endometrial Cancer | Urothelial Cancer | Biliary Tract Cancer | Metastatic Castration-resistant Prostate CancerSpain, China, Korea, Republic of, Canada, Italy, Poland, Turkey, United Kingdom, Japan, Taiwan, United States, France, Germany, Switzerland
-
AbbVieRecruitingColorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Gastroesophageal AdenocarcinomaUnited States, Japan, Puerto Rico, Taiwan, Spain, Australia, France, Israel, Korea, Republic of, Poland
-
Wakayama Medical UniversityCompletedPatients With Borderline Resectable Pancreatic CancerJapan
-
Kyoto UniversityCompleted
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
PfizerRecruitingMelanoma | Neoplasms | Renal Cell Carcinoma | Non-small-cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Colorectal Carcinoma | Ovarian CarcinomaUnited States, Japan, Puerto Rico
-
Astellas Pharma IncCompletedProstate CancerJapan
-
Kyoto UniversityUnknownGastric CancerJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedBreast Cancer | Neoplasm MetastasisJapan
-
Bristol-Myers SquibbCompleted
-
Daiichi Sankyo Co., Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerJapan, United States, Canada
-
University of YamanashiHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Japan Liver Oncology GroupUnknownLiver Cirrhosis | Hepatitis B | Hepatocellular Carcinoma | Hepatitis CJapan
-
Kyowa Kirin, Inc.RecruitingGastric Adenocarcinoma | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
R-PharmCompleted
-
Teikyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Translational Research Center for Medical Innovation...Daiichi Sankyo Co., Ltd.CompletedAlzheimer's Disease Dementia | Cognitive Concern Without DementiaJapan
-
Kindai UniversityUnknownChronic Hepatitis B | Chronic Hepatitis CJapan
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
PfizerCompletedStomach Neoplasms | Advanced Gastric CancerKorea, Republic of, Japan
-
Kyoto University HospitalMerck Sharp & Dohme LLC; Astellas Pharma Inc; University of Tsukuba; Kobe City... and other collaboratorsRecruiting
-
AstraZenecaCompleted
-
ImmunoFrontier, Inc.Completed
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerJapan
-
Novartis PharmaceuticalsCompletedCancer | Renal Cell Carcinoma (RCC)United States, Belgium, Canada, Spain, United Kingdom, Turkey, Austria, Argentina, Brazil, Czechia, France, Germany, Israel, Italy, Poland, Russian Federation, Korea, Republic of, Chile, China, Greece, Hungary, Ireland, Slovakia, Japan, Denmar... and more
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerJapan
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsCompletedEsophageal Cancer | Triple Negative Breast Cancer | Head & Neck CancerFrance, Singapore, Italy, Japan, United States, Spain
-
Chinese University of Hong KongRecruitingGastric Cancer | Intestinal Metaplasia | Atrophic GastritisHong Kong, Japan, Singapore, Thailand
-
Johnson & Johnson International (Singapore) Pte...CompletedHigh Risk Localized Prostate CancerJapan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan